stars 1 stars 2 stars 3

Amass is a scientific intelligence platform for R&D and business development teams in biotech and pharma. We help teams evaluate scientific claims, map competitive landscapes, and make better decisions across pipelines and external opportunities. The platform analyzes publications, patents, clinical trials, regulatory data, and internal sources such as ELNs and company datasets to generate structured, evidence-based insights. Common use cases include: • Scientific due diligence • Pipeline and target evaluation • Competitive intelligence • Literature review and evidence synthesis Used by teams across pharma, biotech, and life science investors. Available as SaaS, API, and enterprise integrations into internal R&D workflows.

amass Questions

Henrik Jensen is the Co-Founder and CEO of amass.

7 people are employed at amass.

Top amass Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users